• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

T2 Biosystems

edit

T2 Biosystems is a private company developing a next-generation medical diagnostic platform that will enable rapid and accurate diagnostic tests of all types on a single, easy to use instrument. The proprietary technology combines nanotechnology and miniaturized magnetic resonance (MR) technology and eliminates the need for costly and time consuming sample preparation.

Milestones

edit

• 
  T2 Biosystems added Michael A. Greeley as Director.
  Posted 11/4/10 at 5:44am
• 
  T2 Biosystems received $23M in Series D funding. (8/10/11)
  Posted 8/10/11 at 5:46pm via masshightech.com
• 
  T2 Biosystems received $15M in Series C funding. (5/26/10)
  Posted 5/26/10 at 5:09pm via onbiovc.com
• 
  T2 Biosystems received $5.5M in Venture Round funding. (1/1/06)
  Posted 4/26/10 at 11:11pm
• 
  T2 Biosystems — secured an Emerging Technology Loan, valued at about $1.7 million, from MassDevelopment, (5/18/11)
  Posted 5/19/11 at 4:48am via masshightech.com
• 
  T2 Biosystems — appointed Kirt Poss as senior vice president of corporate development (3/14/11)
  Posted 3/15/11 at 7:35am via masshightech.com

Videos

Screenshots

edit

Above: T2 Biosystems
Uploaded: 4/27/10

Sources

1. Cap Funding Report [edit]
2. T2 Biosystems, Inc.: Series C $15M (onbiovc.com) [edit]
3. T2 Biosystems closes $23M Series D financing (masshightech.com) [edit]
T2 Biosystems names Poss to new corporate development VP role (masshightech.com) [edit]
T2 Biosystems boosted by $1.7M MassDevelopment loan (masshightech.com) [edit]